Olmesartan,Drugs Manufacturer Worldwide,Exporter,Medicine Supplier,Pharmaceutical Bulk Drugs,Medicine Importer,Drugs Import & Export,Buyers,Sellers,Precautions,Pharmacology,Global,Details,Contraindications,Vaccine,Pharmaceutical Development&Technology,Drugs Research,Fda Approval,Health Codition,Diagnosis, Distributor,Formulations,Informatiom on Injection,Drugs Side Adverse Effects,API Service Provider,Treatment,Surgery,Exporters,Prevention,Active Pharmaceutical Ingredients,Raw Material Supplier,Drugs Exporters,Trading Comany Multivitamin,Dosages,Drug Suppliers India,Vitamins,Export,Taj Pharmaceuticals Ltd.

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Olmesartanis tablets

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

	PRODUCT LIST
	Home
	API
	Pharmaceuticals API List >>
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

pharmacist promptly.

Olmesartanis CAS number 144689-63-4

Olmesartan
CAS number 144689-63-4

Systematic (IUPAC) name
(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylate

Identifiers

ATC code C09CA08
C09DA08 (with diuretics)
C09DB02 (with amlodipine)
PubChem 130881
DrugBank APRD00223

Chemical data

Formula C29H30N6O6
Mol. mass 558.585 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability 26%
Metabolism Hepatic (cannot be removed by hemodialysis)
Half life 13 hours
Excretion Renal 40%, biliary 60%
Therapeutic considerations
Pregnancy cat.
C (D if used in second or third trimester)
Routes Oral

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj pharmaceuticals API Logo

More Api at Taj Pharmaceuticals Ltd.

Lacidipine

Paroxetine

Primidone

	Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.